1 - Thromboembolic events post cytoreductive surgery in patients with ovarian, fallopian tube or primary peritoneal cancer

Mapping Intimacies ◽

10.26226/morressier.5d2ee8e71e09a6f49485a908 ◽

2019 ◽

Author(s):

David Atallah ◽

Malak Moubarak

Keyword(s):

Fallopian Tube ◽

Cytoreductive Surgery ◽

Thromboembolic Events ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

EP933 Thromboembolic events post cytoreductive surgery in patients with ovarian, fallopian tube or primary peritoneal cancer

10.1136/ijgc-2019-esgo.979 ◽

2019 ◽

Author(s):

D Atallah ◽

K Abi Farraj ◽

M Moubarak ◽

N El Kassis ◽

G Chahine

Keyword(s):

Fallopian Tube ◽

Cytoreductive Surgery ◽

Thromboembolic Events ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

91 Thromboembolic events post cytoreductive surgery in patients with ovarian, fallopian tube or primary peritoneal cancer

10.1136/ijgc-2019-igcs.91 ◽

2019 ◽

Author(s):

D Atallah ◽

K Abi Farraj ◽

M Moubarak ◽

N El Kassis ◽

G Chahine

Keyword(s):

Fallopian Tube ◽

Cytoreductive Surgery ◽

Thromboembolic Events ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

Thromboembolic events post cytoreductive surgery in patients with ovarian, fallopian tube or primary peritoneal cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2020.05.204 ◽

2020 ◽

Vol 159 ◽

pp. 148

Author(s):

D. Atallah ◽

M. Moubarak ◽

K. Abi Farraj ◽

N. El Kassis

Keyword(s):

Fallopian Tube ◽

Cytoreductive Surgery ◽

Thromboembolic Events ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

CYTOREDUCTIVE SURGERY (CRS) AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) IN PATIENTS WITH ADVANCED OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER: OUR EXPERIENCE IN 108 PATIENTS

10.26226/morressier.5d2ee8eb1e09a6f49485abf9 ◽

2019 ◽

Author(s):

Mihai Emil Capilna ◽

MIHAI GHEORGHE ◽

Szilard Leo Kiss ◽

Alexandra Lavinia Cozlea

Keyword(s):

Fallopian Tube ◽

Intraperitoneal Chemotherapy ◽

Cytoreductive Surgery ◽

Hyperthermic Intraperitoneal Chemotherapy ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

292 Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced ovarian, fallopian tube or primary peritoneal cancer: our experience in 108 patients

10.1136/ijgc-2019-igcs.292 ◽

2019 ◽

Author(s):

ME Capilna ◽

B Moldovan ◽

C Rad ◽

AA Moldovan ◽

AL Cozlea ◽

...

Keyword(s):

Fallopian Tube ◽

Intraperitoneal Chemotherapy ◽

Cytoreductive Surgery ◽

Hyperthermic Intraperitoneal Chemotherapy ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

EP811 A retrospective study regarding the role of cytoreductive surgery (CRS) and hypertermic intraperitoneal chemotherapy (HIPEC) in patients with advanced ovarian, fallopian tube or primary peritoneal cancer

10.1136/ijgc-2019-esgo.861 ◽

2019 ◽

Author(s):

ME Capilna ◽

B Moldovan ◽

C Rad ◽

AA Moldovan ◽

AL Cozlea

Keyword(s):

Retrospective Study ◽

Fallopian Tube ◽

Intraperitoneal Chemotherapy ◽

Cytoreductive Surgery ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

A phase II randomized study: Outcomes after cytoreductive surgery (CRS) with or without carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) followed by adjuvant chemotherapy as initial treatment of advanced stage (stage III/IV) ovarian, fallopian tube, and primary peritoneal cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e17080 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e17080-e17080

Author(s):

Teresa Diaz-Montes ◽

Michelle Sittig ◽

Hyung Ryu ◽

Vadim Gushchin ◽

Armando Sardi

Keyword(s):

Adjuvant Chemotherapy ◽

Fallopian Tube ◽

Intraperitoneal Chemotherapy ◽

Cytoreductive Surgery ◽

Initial Treatment ◽

Hyperthermic Intraperitoneal Chemotherapy ◽

Randomized Study ◽

Advanced Stage ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary peritoneal cancer (ANZGOG1901/2020)

Journal of Gynecologic Oncology ◽

10.3802/jgo.2022.33.e1 ◽

2022 ◽

Vol 33 ◽

Author(s):

Rhonda Farrell ◽

Michael Burling ◽

Yeh Chen Lee ◽

Selvan Pather ◽

Kristy Robledo ◽

...

Keyword(s):

Clinical Trial ◽

Fallopian Tube ◽

Intraperitoneal Chemotherapy ◽

Cytoreductive Surgery ◽

Stage Iii ◽

Trial Protocol ◽

Primary Peritoneal Cancer ◽

Clinical Trial Protocol ◽

Peritoneal Cancer

Download Full-text

A comparison of outcomes following total and selective peritonectomy performed at the time of interval cytoreductive surgery for advanced serous epithelial ovarian, fallopian tube and primary peritoneal cancer – A study by INDEPSO

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2019.02.031 ◽

2021 ◽

Vol 47 (1) ◽

pp. 75-81 ◽

Author(s):

Snita Sinukumar ◽

Firoz Rajan ◽

Sanket Mehta ◽

Dileep Damodaran ◽

Shabber Zaveri ◽

...

Keyword(s):

Fallopian Tube ◽

Cytoreductive Surgery ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as initial treatment of ovarian, fallopian tube, and primary peritoneal cancer: Preliminary results of a phase II randomized clinical trial

Gynecologic Oncology ◽

10.1016/j.ygyno.2018.04.079 ◽

2018 ◽

Vol 149 ◽

pp. 35

Author(s):

T.P. Diaz-Montes ◽

F. El-Sharkawy ◽

V. Gushchin ◽

H.S. Ryu ◽

M. Sittig ◽

...

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Fallopian Tube ◽

Phase Ii ◽

Intraperitoneal Chemotherapy ◽

Cytoreductive Surgery ◽

Initial Treatment ◽

Hyperthermic Intraperitoneal Chemotherapy ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text